Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMKDGI8)

Drug Name
BP-100-1-01 Drug Info
Indication
Disease Entry ICD 11 Status REF
Acute lymphoblastic leukaemia 2A85 Phase 2 [1]
Acute myeloid leukaemia 2A60 Phase 2 [1]
Chronic myelogenous leukaemia 2A20.0 Phase 2 [1]
Hematologic tumour 2B33.Y Phase 2 [1]
Myelodysplastic syndrome 2A37 Phase 2 [1]
Cross-matching ID
TTD Drug ID
DMKDGI8

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
GRB2 messenger RNA (GRB2 mRNA) TTEYRJ9 GRB2_HUMAN Modulator [2]

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800032443)
2 ClinicalTrials.gov (NCT01159028) Clinical Trial of BP1001 (L-Grb-2 Antisense Oligonucleotide) in CML, AML, ALL & MDS. U.S. National Institutes of Health.